Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group

Flow cytometric analysis of de novo acute myeloid leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group

(2011) Hideaki Ohta et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report

(2011) U Creutzig et al.   LEUKEMIA

Granulocyte Colony-Stimulating Factor (G-CSF) Treatment of Childhood Acute Myeloid Leukemias That Overexpress the Differentiation-DefectiveG-CSFReceptor Isoform IV Is Associated With a Higher Incidence of Relapse

(2010) Stephanie Ehlers et al.   JOURNAL OF CLINICAL ONCOLOGY

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

(2010) Jeffrey E Rubnitz et al.   LANCET ONCOLOGY

Risk-Stratified Therapy and the Intensive Use of Cytarabine Improves the Outcome in Childhood Acute Myeloid Leukemia: The AML99 Trial From the Japanese Childhood AML Cooperative Study Group

(2009) Ichiro Tsukimoto et al.   JOURNAL OF CLINICAL ONCOLOGY

Infant acute lymphoblastic leukemia: Lessons learned and future directions

(2009) Rob Pieters   Current Hematologic Malignancy Reports

Incidence, Predisposing Factors, and Outcome of Engraftment Syndrome in Pediatric Allogeneic Stem Cell Transplant Recipients

(2008) Irene Schmid et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Respiratory syncytial virus infections in children with acute myeloid leukemia: A report from the Children's Oncology Group

(2008) Lillian Sung et al.   PEDIATRIC BLOOD & CANCER

Graft versus leukemia effect after haploidentical HSCT in a MLL-negative infant AML with HLXB9/ETV6 rearrangement

(2007) Julia Hauer et al.   PEDIATRIC BLOOD & CANCER